-
Carbenoxolone disodium: Practical Lab Guide
2026-09-14
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in cell- and tissue-based mechanistic workflows with matched vehicle, viability, and orthogonal controls, rather than as a selective in vivo efficacy probe or clinical treatment.
-
FAISL, FAK Stability, and TNBC Metastasis
2026-09-14
A 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis, thereby promoting adhesion, survival, progression, and metastasis in triple-negative breast cancer. The work connects RNA–protein interaction biology with FAK turnover and provides preclinical evidence for targeting FAISL with reduction-responsive siRNA nanoparticles.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-13
Build a reproducible PEI-based workflow for HEK-293 transfection, transient gene expression, and recombinant protein production. Practical screening conditions, scale-up guidance, and lessons from calcium-phosphate optimization help separate true process effects from DNA, volume, and cell-health variables.
-
SW033291: 15-PGDH Inhibitor Workflow
2026-09-12
SW033291 is a small molecule 15-PGDH inhibitor for testing endogenous prostaglandin E2 elevation across biochemical, cellular, hematopoietic, and tissue-repair models. This workflow connects target engagement with practical readouts for hematopoiesis stimulation and muscle-focused tissue regeneration research while keeping translational limitations explicit.
-
Angiotensin I/II (1-5): RAS Workflow Guide
2026-09-11
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research. It is suited to cardiovascular and renal workflows involving blood pressure or aldosterone pathways, but should not be extrapolated to unrelated signaling studies or clinical use without independent validation.
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-09-11
The reference study demonstrates that compression-induced autophagy depends strongly on cytoskeletal microfilaments, while microtubules provide a secondary contribution. By combining mechanical loading with cytoskeletal polymerization perturbation, the work clarifies how physical forces may be converted into autophagy signals and provides a useful framework for mechanotransduction experiments.
-
Z-VAD-FMK: Mechanism, Uses, and Limits
2026-09-10
Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor used for apoptosis inhibition and apoptotic pathway research. Its strongest use is causal pathway testing, but it does not establish that a cell death phenotype is apoptotic or directly inhibit the MLKL machinery of necroptosis.
-
Gefitinib in Gastric Cancer Assembloids
2026-09-09
Gefitinib (ZD1839) is more than an EGFR inhibitor in gastric cancer research: it can function as a perturbational probe of tumor–stroma drug response. This guide translates patient-derived assembloid findings into practical assay design, mechanistic readouts, and interpretation strategies.
-
Sodium Oxamate: LDH-A Workflow Guide
2026-09-09
Sodium Oxamate helps researchers connect LDH-A activity, lactate production, and downstream cell-state changes in cancer and neural injury models. This practical guide covers water-based dosing, lactylation-focused readouts, assay controls, and troubleshooting for stronger metabolic conclusions.
-
AC008406.3, Cuproptosis, and Docetaxel Response
2026-09-08
A 2026 study identifies the long non-coding RNA AC008406.3 as a suppressor of cuproptosis and a contributor to docetaxel insensitivity in breast cancer. Its integrated bioinformatics, genetic perturbation, and drug-response experiments suggest that AC008406.3 knockdown may improve docetaxel activity by restoring copper-dependent cancer cell death.
-
Neurotensin: NTR1 Assay Workflow and Optimization
2026-09-08
Neurotensin provides a practical way to connect NTR1 signaling with receptor recycling and miR-133α modulation in gastrointestinal models. This workflow combines peptide handling, GPCR trafficking measurements, miRNA analysis, and interference-aware optical quality control without overstating findings from an unrelated fluorescence-classification study.
-
Humanized Mice Clarify HD56 Prodrug Metabolism
2026-09-07
The 2025 Drug Metabolism and Disposition study shows that humanized-liver mice can resolve species-dependent metabolism of the carboxylate ester prodrug HD56 and improve in vivo–in vitro correlation. Its findings support a more human-relevant strategy for evaluating CES-activated prodrugs before clinical development.
-
Pexidartinib (PLX3397) Assay Guide
2026-09-07
A scenario-based guide to using Pexidartinib (PLX3397), SKU B5854, in macrophage, tumor microenvironment, viability, and cytotoxicity workflows. It connects CSF1R biology with practical controls, solvent handling, data interpretation, and evidence-based product selection.
-
Pollen Interference in EEM Hazardous-Substance Detection
2026-09-05
Zhang and colleagues developed a fluorescence-data processing strategy to reduce pollen interference when classifying hazardous biological substances. Their combination of spectral transformations and random forest classification improved recognition performance, illustrating how computational preprocessing can strengthen rapid bioaerosol screening without relying on pollen removal alone.
-
Human ClpP Activators: Design and Cancer Biology
2026-09-04
The 2025 Future Medicinal Chemistry review organizes recent strategies for activating or inhibiting human mitochondrial ClpP, emphasizing mechanism-based design and structure–activity relationships. Its discussion of optimized activators such as ZK53 connects selective ClpP modulation with mitochondrial proteostasis failure, cell-cycle arrest, apoptosis, and ferroptosis sensitization in cancer models.